Byakangelicin protects against carbon tetrachloride–induced liver injury and fibrosis in mice

Liver fibrosis is a disease caused by long‐term damage that is related to a number of factors. The current research on the treatment of liver fibrosis mainly focuses on the activation of hepatic stellate cell, in addition to protecting liver cells. byakangelicin has certain anti‐inflammatory ability...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaohe, Shao, Shuaibo, Li, Hailong, Bi, Zhun, Zhang, Shanshan, Wei, Yiying, Bai, Jiakun, Zhang, Ruotong, Ma, Xiaoyang, Ma, Bowei, Zhang, Liang, Xie, Chunfeng, Ning, Wen, Zhou, Honggang, Yang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412405/
https://www.ncbi.nlm.nih.gov/pubmed/32643868
http://dx.doi.org/10.1111/jcmm.15493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412405/
https://www.ncbi.nlm.nih.gov/pubmed/32643868
http://dx.doi.org/10.1111/jcmm.15493

Ejemplares similares